Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Receivables (2016 - 2022)

Aethlon Medical (AEMD) has disclosed Change in Receivables for 10 consecutive years, with -$114849.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Change in Receivables changed N/A year-over-year to -$114849.0, compared with a TTM value of -$114849.0 through Sep 2023, down 570.96%, and an annual FY2023 reading of -$127965.0, down 505.98% over the prior year.
  • Change in Receivables was -$114849.0 for Q4 2022 at Aethlon Medical, down from -$13116.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $206729.0 in Q4 2019 and bottomed at -$114849.0 in Q4 2022.
  • Average Change in Receivables over 5 years is $8312.6, with a median of -$4001.0 recorded in 2022.
  • Peak annual rise in Change in Receivables hit 23.37% in 2022, while the deepest fall reached 111.69% in 2022.
  • Year by year, Change in Receivables stood at $74813.0 in 2018, then soared by 176.33% to $206729.0 in 2019, then plummeted by 98.55% to $3000.0 in 2020, then tumbled by 670.53% to -$17116.0 in 2021, then plummeted by 571.0% to -$114849.0 in 2022.
  • Business Quant data shows Change in Receivables for AEMD at -$114849.0 in Q4 2022, -$13116.0 in Q2 2022, and -$4001.0 in Q1 2022.